188 related articles for article (PubMed ID: 30666586)
41. The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis.
Tleyjeh IM; Steckelberg JM; Georgescu G; Ghomrawi HM; Hoskin TL; Enders FB; Mookadam F; Huskins WC; Wilson WR; Baddour LM
Heart; 2008 Jul; 94(7):892-6. PubMed ID: 18308866
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous aortic and mitral valve replacement in children: time-related outcomes and risk factors.
Alsoufi B; Al-Halees Z; Fadel B; Al-Wesabi A; Al-Ahmadi M; Joufan M; Siblini G; Canver CC
J Heart Valve Dis; 2010 May; 19(3):341-8. PubMed ID: 20583397
[TBL] [Abstract][Full Text] [Related]
43. Long-term experience with the omniscience cardiac valve.
Teijeira FJ
J Heart Valve Dis; 1998 Sep; 7(5):540-7. PubMed ID: 9793854
[TBL] [Abstract][Full Text] [Related]
44. Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation.
Martínez-Sellés M; Bouza E; Díez-Villanueva P; Valerio M; Fariñas MC; Muñoz-García AJ; Ruiz-Morales J; Gálvez-Acebal J; Antorrena I; de la Hera Galarza JM; Navas E; Muñoz P;
EuroIntervention; 2016 Feb; 11(10):1180-7. PubMed ID: 25671426
[TBL] [Abstract][Full Text] [Related]
45. Outcomes and associated risk factors for mitral valve replacement in children.
Alsoufi B; Manlhiot C; Al-Ahmadi M; McCrindle BW; Kalloghlian A; Siblini G; Bulbul Z; Al-Halees Z
Eur J Cardiothorac Surg; 2011 Sep; 40(3):543-51. PubMed ID: 21353791
[TBL] [Abstract][Full Text] [Related]
46. Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus.
Borger MA; Yau TM; Rao V; Scully HE; David TE
Ann Thorac Surg; 2002 Nov; 74(5):1482-7. PubMed ID: 12440596
[TBL] [Abstract][Full Text] [Related]
47. Mitral valve repair and replacement in endocarditis: a systematic review of literature.
Feringa HH; Shaw LJ; Poldermans D; Hoeks S; van der Wall EE; Dion RA; Bax JJ
Ann Thorac Surg; 2007 Feb; 83(2):564-70. PubMed ID: 17257988
[TBL] [Abstract][Full Text] [Related]
48. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair.
Shang E; Forrest GN; Chizmar T; Chim J; Brown JM; Zhan M; Zoarski GH; Griffith BP; Gammie JS
Ann Thorac Surg; 2009 Jun; 87(6):1728-33; discussion 1734. PubMed ID: 19463586
[TBL] [Abstract][Full Text] [Related]
49. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment.
Siniawski H; Grauhan O; Hofmann M; Pasic M; Weng Y; Yankah C; Lehmkuhl H; Hetzer R
Eur J Cardiothorac Surg; 2005 Mar; 27(3):434-40. PubMed ID: 15740952
[TBL] [Abstract][Full Text] [Related]
50. Surgery for infective endocarditis: determinate factors in the outcome.
Ishikawa S; Kawasaki A; Neya K; Abe K; Suzuki H; Kadowaki S; Nakamura K; Ueda K
J Cardiovasc Surg (Torino); 2008 Aug; 49(4):545-8. PubMed ID: 18665120
[TBL] [Abstract][Full Text] [Related]
51. Prosthesis-patient mismatch after mitral valve replacement stratified by referred and measured effective valve area.
Matsuura K; Mogi K; Aoki C; Takahara Y
Ann Thorac Cardiovasc Surg; 2011; 17(2):153-9. PubMed ID: 21597412
[TBL] [Abstract][Full Text] [Related]
52. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
[TBL] [Abstract][Full Text] [Related]
53. Surgical repair and replacement for native mitral valve infective endocarditis.
Malvindi PG; Luthra S; Zingale A; Bifulco O; Berretta P; Pierri MD; Ohri SK; Di Eusanio M
J Cardiovasc Med (Hagerstown); 2024 Apr; 25(4):334-341. PubMed ID: 38407841
[TBL] [Abstract][Full Text] [Related]
54. Mitral valve repair for disruptive acute endocarditis: extensive replacement of posterior leaflet with bovine pericardium.
Nwaejike N; Ascione R
J Card Surg; 2011 Jan; 26(1):31-3. PubMed ID: 21158916
[TBL] [Abstract][Full Text] [Related]
55. Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices.
Aagaard J; Andersen PV
Ann Thorac Surg; 2001 Jan; 71(1):100-3; discussion 104. PubMed ID: 11216726
[TBL] [Abstract][Full Text] [Related]
56. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
[TBL] [Abstract][Full Text] [Related]
57. Outcome of surgical management for active mitral native valve infective endocarditis: a collective review of 57 patients.
Miura T; Hamawaki M; Hazama S; Hashizume K; Ariyoshi T; Sumi M; Furumoto A; Saito N; Tsuneto A; Eishi K
Gen Thorac Cardiovasc Surg; 2014 Aug; 62(8):488-98. PubMed ID: 24522750
[TBL] [Abstract][Full Text] [Related]
58. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.
Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM;
Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200
[TBL] [Abstract][Full Text] [Related]
59. Clinical Presentation of Native Mitral Valve Infective Endocarditis Determines Long-Term Outcome after Surgery.
Ragnarsson S; Sjögren J; Stagmo M; Wierup P; Nozohoor S
J Card Surg; 2015 Sep; 30(9):669-76. PubMed ID: 26123359
[TBL] [Abstract][Full Text] [Related]
60. Eighteen-year follow up after Hancock II bioprosthesis insertion.
Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
